Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,306 | -2,755 | 4,777 | 31,513 | 13,190 |
| Depreciation Amortization | 1,959 | 2,581 | 2,204 | 478 | 251 |
| Income taxes - deferred | 26,228 | -99 | 13 | -4,214 | 4,262 |
| Accounts receivable | -3,885 | -218 | 32 | 1,016 | -23 |
| Accounts payable and accrued liabilities | 2,872 | 893 | 1,679 | 831 | 924 |
| Other Working Capital | -4,734 | -4,338 | -2,039 | 2,696 | -18,799 |
| Other Operating Activity | -25,125 | 586 | -1,697 | -808 | 5,844 |
| Operating Cash Flow | $-19,991 | $-3,350 | $4,969 | $31,512 | $5,649 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 33,447 | 31,490 | -32,045 | -1,069 | -31,553 |
| PPE Investments | -259 | -328 | -495 | -477 | -2,231 |
| Net Acquisitions | N/A | -28,118 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3,000 | N/A | -2,915 | N/A | N/A |
| Other Investing Activity | -5,287 | -14,900 | -2,915 | 12,007 | 0 |
| Investing Cash Flow | $27,901 | $-11,856 | $-35,455 | $10,461 | $-33,784 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 12,079 | N/A | N/A | N/A |
| Debt Repayment | -7,500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 119 | 14 | 19 | 878 | 31,341 |
| Common Stock Repurchased | -700 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | -13,728 | -2,865 | -31,150 | N/A |
| Financing Cash Flow | $-8,081 | $-1,635 | $-2,846 | $-30,272 | $31,341 |
| Exchange Rate Effect | 1,590 | 4,664 | 1,048 | 4,091 | -128 |
| Beginning Cash Position | 49,243 | 61,420 | 93,704 | 77,912 | 22,481 |
| End Cash Position | 50,662 | 49,243 | 61,420 | 93,704 | 25,559 |
| Net Cash Flow | $1,419 | $-12,177 | $-32,284 | $15,792 | $3,078 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,991 | -3,350 | 4,969 | 31,512 | 5,649 |
| Capital Expenditure | -284 | -333 | -495 | -489 | -2,231 |
| Free Cash Flow | -20,275 | -3,683 | 4,474 | 31,023 | 3,418 |